Monogram is currently running a crowdfunding campaign that is open to the public. Any interested parties now have the opportunity to own shares in innovative and personalized orthopedic care. Visit Monogram’s website to learn more.

There are nearly 1 million knee and hip replacements in the U.S. alone every year, and that number keeps growing. Almost 1.27 million patients could undergo total knee arthroplasty (TKA) in the U.S. by 2025, and they are trending younger, more active, and/or more obese, all of which increase demands on the implants.

Despite this remarkable growth and significant market opportunity, the pace of innovation in orthopedics has been languid. We're living in the 21st century, but what do we see? Crude and finicky instruments are the tools of choice - saws, hammers, and jigs, along with cemented generic implants that don't always fit right and that can crack and loosen over time. The prospect of putting that in your body isn't very exciting. 

The results aren't perfect either, with 9.6% knee failure rates and double-digit failure rates on hips. Patients can endure complications like infection, implant breakage, stiff joints, chronic pain, and the list goes on.

Sounds pretty bad, right? So why is this the case? One answer could be a scarcity of small innovative companies and consolidation. Four enormous companies that are collectively almost 400 years old lead the joint replacement market. The top four companies account for 82% of the knee market. The result is glacial progress and an industry that isn't doing enough to drive the pace of innovation to improve patient outcomes. 

It's bad enough to have to undergo knee or hip surgery, but even worse when you have to live with chronic pain and a nasty medical bill. Market inefficiencies can drive up the cost of care, which could improve with a more streamlined surgical workflow at a lower cost. Things have to change. 

One ambitious company is stepping up to the challenge, unphased that many have tried to do the same and failed. They're already making great strides, and the simple belief backs them that people deserve better. 

Monogram Orthopedics is ushering in personalized orthopedic care by combining proprietary 3D printing technology with next-generation navigated surgical robotics.

"We are poised to do what no other company has done in the total joint reconstruction market before - harness technology to build truly personalized implants that fully tap into the power of intelligent robotics," said Dr. Doug Unis, Founder of Monogram and board-certified orthopedic surgeon.

How It Works:

  1. The surgeon initiates a CT scan that creates a precise 3D model of the patient bone structure
  2. Monogram makes a patient-specific plan using machine learning algorithms
  3. The company starts 3D-printing of the patient optimized titanium alloy press-fit implant
  4. The surgical robot precisely mills the bone cavity and implants the prosthetic

The company is breaking new ground on many fronts, starting with the seven joint navigated robot arm that actively cuts bone based on optimized cut paths without direct manual control. While the surgeon does control the speed of the arm, the heavy lifting is done by sophisticated algorithms behind the scenes. 

Monogram is also popularizing the use of press-fit over cemented implants. Currently, surgeons affix 90% of TKAs with bone cement. While cemented fixation is now the gold standard, it's conceived for an older, less demanding population. Cemented prosthetics can break and cause problems over time. Porous metal press-fit implants allow the bone to fuse to the metal and hold it in place naturally. 

Technology improvements could mitigate several post-operative patient issues with improved technology and better performing implants. The Monogram Orthopaedics Inc. ("Monogram") solution represents the next generation of implants that greatly enhance stability, bone ‎loading, and revisability.

Monogram's next-level technology and integrated system is designed to try and address these limitations. Thanks to their customized, stable implants and precise installation, Monogram could significantly reduce the risk of fracture and complications that can occur after the surgery.

In a world facing rapidly rising numbers of joint procedures, the need for this technology couldn't be more apparent, and Monogram is ready to help be a driver of this positive change for patients. Patients are best served when companies are forced to innovate and rather than stagnate.

"Our mission has always been to make orthopedics personal, which is a change from the current standard of care in this industry," said CEO Benjamin Sexson. "Patients and healthcare providers would all benefit from advanced technology that changes the paradigm and modernizes orthopedic techniques." 

Join in on the joint replacement revolution. Visit

This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view Monogram Orthopedics offering circular as well as the risks associated with this offering.